Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs RSG✓SelectedUSD · RSGGSK vs RSG performance historyLatest closeAs of-1.34%11/18
Stock and ETF performance explorer

GSK vs RSG

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+42.8%
RSG return
+93.0%
Excess return
-50.2%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioRSGExcessAlpha
1D-1.3%-1.5%+0.2%-0.9%
7D-3.1%-0.1%-3.1%-3.1%
30D-0.9%+8.8%-9.7%-3.4%
3M-4.2%+15.2%-19.4%-8.1%
6M-1.6%+16.9%-18.5%-6.1%
YTD+2.6%+19.0%-16.4%-2.8%
1Y+6.2%+17.9%-11.6%+0.9%
3Y+55.0%+62.4%-7.5%+34.5%
5Y+42.8%+93.0%-50.1%+17.8%
All+42.8%+93.0%-50.2%+17.8%

Cumulative growth

Daily Returns

Daily percentage return beside RSG.

Daily Out/Under-Performance

Portfolio return minus RSG return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × RSG return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded RSG wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling